資源描述:
《經(jīng)肝動脈熱化療栓塞在晚期肝癌治療中的臨床應(yīng)用》由會員上傳分享,免費(fèi)在線閱讀,更多相關(guān)內(nèi)容在工程資料-天天文庫。
1、經(jīng)肝動脈熱化療栓塞在晚期肝癌治療中的臨床應(yīng)用【摘要】目的:探討經(jīng)肝動脈熱化療栓塞在晚期肝癌治療中的臨床應(yīng)用價(jià)值。方法:選取2011年1月-2013年11月本院收治的原發(fā)性肝癌晚期患者92例作為研宄對象,依據(jù)隨機(jī)分配原則分為熱化療栓塞組和對照組,每組46例。對照組患者給予常規(guī)經(jīng)肝動脈化療栓塞治療,熱化療栓塞組患者給予經(jīng)肝動脈熱化療栓塞治療(藥物及腆油加熱到60°C),檢測分析所有患者治療前后外周血中丙氨酸氨基轉(zhuǎn)移酶(ALT)、天冬氨酸氨基轉(zhuǎn)移酶(AST)及總膽紅素(TBIL)水平變化;隨訪24個(gè)月,統(tǒng)計(jì)分析所有患者有效
2、率和6、12、18、24個(gè)月的生存率。結(jié)果:熱化療栓塞組有效率為80.43%,明顯高于對照組的58.70%,比較差異有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論:經(jīng)肝動脈熱化療栓塞治療可有效提高晚期肝癌患者的療效,有利于延長患者的生存時(shí)間,值得臨床進(jìn)一步推【關(guān)鍵詞】經(jīng)肝動脈熱化療栓塞;化療栓塞;晚期肝癌;生存率ClinicalApplicationofThermochemoembolizationViaHepaticArteryintheTreatmentofAdvancedLiverCancer/CHENGYu,ZHANGSh
3、eng,RAOXiao-hui,etal.//MedicalInnovationofChina,2016,13(22):051-055【Abstract】Objective:Todiscusstheapplicationvalueofthermochemoembolizationviahepaticarteryinthetreatmentofadvancedlivercancer.Method:FromJanuary2011toNovember2013,92casesofadvancedlivercancerinou
4、rhospitalwereselectedastheresearchobjects,theyweredividedintothethermochemoembolizationgroupandcontrolgroupaccordingtotheprincipleofrandomdistribution,eachgrouphad46cases.Thecontrolgroupreceivedstandardchemoembolizationtherapyviahepaticartery,andthermochemoembo
5、lizationgroupreceivedchemoembolizationwithdrugsheatedto60°Cviahepaticartery.Beforeandafterthetreatment,thelevelsofserumalanineaminotransferase(ALT),aspartateaminotransferase(AST)andtotalbilirubin(TBIL)weredetectedandanalyzed.Allpatientswerefollowedupfor24months
6、,effectiveremissionrateandsurvivalrateof6,12,18,24monthswerestatisticalanalyzed.Result:Thermochemoembolizationgroupeffectiveremissionratewas80.43%,significantlyhigherthan58.70%ofthecontrolgroup,thedifferenceswasstatisticallysignificant(P0.05).Conclusions:Thermo
7、chemoembolizationviahepaticarterycaneffectivelyimprovethecurativeeffectofpatientswithadvancedlivercancer,andisbeneficialtoextendthesurvivaltimeofthesepatients,itisworthoffurtherclinicalpromotion.【Keywords】Thermochemoembolization;Chemoembolization;Advancedliverc
8、ancer;SurvivalrateFirst-author’saddress:CentralPeople'sHospitalofHuizhouCity,Huizhou516001,China2.3兩組患者治療前后外周血中ALT、AST及TBIL水平比較兩組患者治療前外周血中ALT、AST及TBIL水平比較差異均無統(tǒng)計(jì)學(xué)意義(P>0.05);治